<DOC>
	<DOCNO>NCT00617279</DOCNO>
	<brief_summary>The primary patency GORE PROPATEN Vascular Graft equivalent well disadvantage autologous vein graft infragenicular peripheral bypass application 12 month .</brief_summary>
	<brief_title>GORE PROPATEN Vascular Graft v . Disadvantaged Autologous Vein Graft</brief_title>
	<detailed_description>Primary patency define hemodynamic evidence blood flow open graft maintain uninterrupted patency previously undergone revision restore blood flow . A disadvantaged autologous vein define meet least one two follow criterion : ( 1 ) Any autologous vein ( ) great saphenous vein deem usable Investigator ; ( 2 ) Usable ipsilateral contralateral autologous great saphenous vein meet follow criterion : ( ) Diameter le equal 3.0 mm ; ( b ) Inadequate length require splicing ; ( c ) Poor quality vein either sclerotic phlebitic .</detailed_description>
	<mesh_term>Arterial Occlusive Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<criteria>1 . Patient require belowknee bypass secondary severe claudication , rest pain tissue loss due peripheral arterial occlusive disease . 2 . Patient meet disadvantage autologous vein criterion describe Section 4.1 . 3 . Patient postoperative life expectancy great one year . 4 . Patient least 21 year age . 5 . Patient able comply study requirement available followup visit 1 , 6 , 12 , 24 36months postprocedure . 6 . Patient willing able provide write , informed consent . 1 . Patient previous instance Heparin Induced Thrombocytopenia type 2 ( HIT2 ) know hypersensitivity heparin . 2 . Patient require infragenicular bypass reason peripheral arterial occlusive disease . 3 . Patient require sequential extremity revascularizations procedure require use additional vascular graft . 4 . Patient need , schedule , cardiac surgical procedure different vascular surgical procedure within 30 day study procedure . However , inflow procedure facilitate bypass permit , long perform sit bypass procedure . 5 . Patient previously randomize study . 6 . Patient active infection region graft placement .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
</DOC>